METHODS: Male SD rats at 8 weeks old were used. Prostatic inflammation was induced by 5% formalin injection into ventral lobes of the prostate and saline was injected in the control group (Sham). Rats with prostatic inflammation were divided into COX-2 inhibitor (celecoxib) therapy (Treatment) and placebo groups (Placebo). Rats were treated with celecoxib at a dose of 10mg/kg daily from 2 days before induction of prostatic inflammation. Twenty-eight days later, conscious cystometry was performed to assess bladder function. After cystometry, the prostate and L6-S1 dorsal root ganglia (DRG) were excised for analysis of mRNA expression levels of IL1b and COX-2 in the prostate and a Kþ channel a-subunit, Kv1.4, in DRG as well as histological evaluation of prostate and bladder.
INTRODUCTION AND OBJECTIVES:
Chronic inflammation is thought to contribute to the development of prostatitis and benign prostatic hyperplasia (BPH). In the prostate, the epithelial barrier functions to provide a selectively permeable barrier which serves as an interface between the glandular lumen and the underlying tissues. Ecadherin is an important adherens junction that helps to maintain the epithelial barrier in mucous membranes. This study explored the potential impact of reduced barrier function induced by deletion of Ecadherin in the murine prostate.
METHODS: The PSA-CreERT2 transgenic mouse strain expressing tamoxifen-inducible CreERT2 recombinase driven by a 6-kb human PSA promoter/enhancer was crossed with the B6.129-Cdh1tm2Kem/J mouse to generate bigenic PSA-CreERT2/Cdh1-/-mice. Deletion of E-cadherin was performed by transient administration of tamoxifen when mice reached sexual maturity (7 weeks of age). Void Spot Assays and cystometry were used to assess bladder function. Mice were examined histologically at 150 days and 365 days of age.
RESULTS: Mice with Cdh1 deletion had increased proliferation, inflammation, and stromal fibrosis at 150 days of age, as well as potential changes in bladder voiding. These alterations persisted at 365 days of age, suggesting that the loss of E-cadherin could contribute to the development of a chronically inflamed prostate.
CONCLUSIONS: These findings suggest that loss of epithelial barrier integrity in the prostate could result in chronic inflammation and the development of stromal fibrosis, inflammation and benign epithelial hyperplasia characteristic of BPH and prostatitis. However, its role has never been determined in the prostate. The current study aimed to elucidate the roles of IL-21R in the development of BPH.
METHODS: Human prostate tissues, cell lines and rats were used. The expression and localization of IL-21R were determined with quantitative real-time PCR (qRT-PCR), Western Blot, and immunohistochemistry staining. BPH-1 cells with IL-21R silenced were cultured or co-cultured with macrophages (active THP-1, AcTHP-1).
Apoptosis and cell cycles were tested with Flow Cytometry and Western Blot. Epithelial-mesenchymal transition (EMT) processes were detected with Western Blot and immunofluorescent staining. In vivo, rat prostatitis concomitant with BPH model was induced through intraprostatic injection of lipopolysaccharide (LPS). Rat prostate was observed with Hematoxylin and Eosin (H & E) staining and masson's trichrome staining. The expression and localization of IL-21R in rat prostate were also examined.
RESULTS: IL-21R was found to be highly expressed in human, as well as rat, prostate, mainly in the epithelial compartment. BPH concomitant with prostatitis significantly upregulated the expression of IL-21R. Knockdown of IL-21R induced cell apoptosis and cycle arrest at G0/G1 phase, and blocked EMT processes in BPH-1 cells. When IL-21R silenced BPH-1 cells were co-cultured with AcTHP-1 cells, these aforementioned processes and IL-21R were completely reversed. Prostatic hyperplasia was associated with IL-21R upregulation in the LPS induced prostatitic rat. CONCLUSIONS: Our novel data suggests modulated expression functional activity of IL-21R in the development of BPH. IL-21R mainly localized in prostate epithelium and it was upregulated in hyperplastic prostate tissues. IL-21R enhanced proliferation of BPH-1 cells, via inhibition of cell apoptosis and modulating cell cycles, as well as EMT processes in the case of inflammatory stimuli.
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